vs

Side-by-side financial comparison of HARTE HANKS INC (HHS) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $39.9M, roughly 1.0× HARTE HANKS INC). HARTE HANKS INC runs the higher net margin — 5.5% vs -17.2%, a 22.8% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -15.4%). Neuronetics, Inc. produced more free cash flow last quarter ($692.0K vs $-686.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -6.4%).

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

HHS vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
1.0× larger
STIM
$41.8M
$39.9M
HHS
Growing faster (revenue YoY)
STIM
STIM
+101.2% gap
STIM
85.7%
-15.4%
HHS
Higher net margin
HHS
HHS
22.8% more per $
HHS
5.5%
-17.2%
STIM
More free cash flow
STIM
STIM
$1.4M more FCF
STIM
$692.0K
$-686.0K
HHS
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
-6.4%
HHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HHS
HHS
STIM
STIM
Revenue
$39.9M
$41.8M
Net Profit
$2.2M
$-7.2M
Gross Margin
52.0%
Operating Margin
-0.3%
-12.1%
Net Margin
5.5%
-17.2%
Revenue YoY
-15.4%
85.7%
Net Profit YoY
43.2%
EPS (diluted)
$0.30
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HHS
HHS
STIM
STIM
Q4 25
$39.9M
$41.8M
Q3 25
$39.5M
$37.3M
Q2 25
$38.6M
$38.1M
Q1 25
$41.6M
$32.0M
Q4 24
$47.1M
$22.5M
Q3 24
$47.6M
$18.5M
Q2 24
$45.0M
$16.4M
Q1 24
$45.4M
$17.4M
Net Profit
HHS
HHS
STIM
STIM
Q4 25
$2.2M
$-7.2M
Q3 25
$-2.3M
$-9.0M
Q2 25
$-335.0K
$-10.1M
Q1 25
$-392.0K
$-12.7M
Q4 24
$-12.7M
Q3 24
$142.0K
$-13.3M
Q2 24
$-27.8M
$-9.8M
Q1 24
$-171.0K
$-7.9M
Gross Margin
HHS
HHS
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
HHS
HHS
STIM
STIM
Q4 25
-0.3%
-12.1%
Q3 25
1.3%
-19.6%
Q2 25
0.1%
-21.1%
Q1 25
-0.1%
-34.4%
Q4 24
-3.3%
-51.0%
Q3 24
4.0%
-41.7%
Q2 24
3.0%
-51.7%
Q1 24
0.8%
-39.4%
Net Margin
HHS
HHS
STIM
STIM
Q4 25
5.5%
-17.2%
Q3 25
-5.8%
-24.3%
Q2 25
-0.9%
-26.6%
Q1 25
-0.9%
-39.6%
Q4 24
-56.4%
Q3 24
0.3%
-72.0%
Q2 24
-61.8%
-59.8%
Q1 24
-0.4%
-45.2%
EPS (diluted)
HHS
HHS
STIM
STIM
Q4 25
$0.30
$-0.10
Q3 25
$-0.31
$-0.13
Q2 25
$-0.05
$-0.15
Q1 25
$-0.05
$-0.21
Q4 24
$-0.31
$-0.34
Q3 24
$0.02
$-0.44
Q2 24
$-3.84
$-0.33
Q1 24
$-0.02
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HHS
HHS
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$5.6M
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$20.5M
$22.4M
Total Assets
$91.8M
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HHS
HHS
STIM
STIM
Q4 25
$5.6M
$28.1M
Q3 25
$6.5M
$28.0M
Q2 25
$4.8M
$11.0M
Q1 25
$9.0M
$20.2M
Q4 24
$9.8M
$18.5M
Q3 24
$5.9M
$20.9M
Q2 24
$11.0M
$42.6M
Q1 24
$11.5M
$47.7M
Total Debt
HHS
HHS
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
HHS
HHS
STIM
STIM
Q4 25
$20.5M
$22.4M
Q3 25
$19.9M
$27.4M
Q2 25
$22.2M
$27.1M
Q1 25
$21.4M
$35.5M
Q4 24
$21.7M
$27.7M
Q3 24
$21.0M
$9.4M
Q2 24
$20.6M
$19.4M
Q1 24
$20.0M
$27.7M
Total Assets
HHS
HHS
STIM
STIM
Q4 25
$91.8M
$141.6M
Q3 25
$92.7M
$145.5M
Q2 25
$95.0M
$134.7M
Q1 25
$100.6M
$142.0M
Q4 24
$101.8M
$140.9M
Q3 24
$108.1M
Q2 24
$109.7M
$96.8M
Q1 24
$113.4M
$103.8M
Debt / Equity
HHS
HHS
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HHS
HHS
STIM
STIM
Operating Cash FlowLast quarter
$737.0K
$908.0K
Free Cash FlowOCF − Capex
$-686.0K
$692.0K
FCF MarginFCF / Revenue
-1.7%
1.7%
Capex IntensityCapex / Revenue
3.6%
0.5%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HHS
HHS
STIM
STIM
Q4 25
$737.0K
$908.0K
Q3 25
$3.2M
$-785.0K
Q2 25
$-4.8M
$-3.5M
Q1 25
$-818.0K
$-17.0M
Q4 24
$4.0M
$-8.6M
Q3 24
$-2.9M
$-5.4M
Q2 24
$1.6M
$-5.0M
Q1 24
$-5.7M
$-12.0M
Free Cash Flow
HHS
HHS
STIM
STIM
Q4 25
$-686.0K
$692.0K
Q3 25
$2.2M
$-899.0K
Q2 25
$-5.1M
$-3.8M
Q1 25
$-923.0K
$-17.2M
Q4 24
$3.4M
$-8.7M
Q3 24
$-4.9M
$-5.8M
Q2 24
$926.0K
$-5.6M
Q1 24
$-6.2M
$-12.4M
FCF Margin
HHS
HHS
STIM
STIM
Q4 25
-1.7%
1.7%
Q3 25
5.5%
-2.4%
Q2 25
-13.1%
-9.9%
Q1 25
-2.2%
-53.8%
Q4 24
7.3%
-38.6%
Q3 24
-10.2%
-31.3%
Q2 24
2.1%
-34.0%
Q1 24
-13.7%
-71.1%
Capex Intensity
HHS
HHS
STIM
STIM
Q4 25
3.6%
0.5%
Q3 25
2.5%
0.3%
Q2 25
0.6%
0.7%
Q1 25
0.3%
0.7%
Q4 24
1.3%
0.4%
Q3 24
4.0%
2.1%
Q2 24
1.5%
3.7%
Q1 24
1.2%
2.2%
Cash Conversion
HHS
HHS
STIM
STIM
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-20.76×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

STIM
STIM

Segment breakdown not available.

Related Comparisons